InsidersTradesSigma
Total declarations
Company
▲ Purchases (23 ops.)
▼ Sales (0 ops.)
Browse the detailed record of transactions filed by Ostronic Francis Patrick, Director. Director active across 1 company, notably Cyclo Therapeutics, Inc.. In total, 29 reports have been recorded. Breakdown: 23 buys · 0 sell. Total volume traded: €210k. Activity tracked since 29 October 2021. The latest transaction was disclosed on 20 May 2022 (Acquisition). Regulator: SEC (Form 4). The full history is free.
Declarations29 total
12 shares@ US$2.000.0% of flowCommon StockSEC:0001437749-22-013286:0
Ideal exit: 14 Feb 2023 (T+270)
5,249 shares0Common StockSEC:0001437749-22-010958:0
5,000 shares@ US$2.905.3% of flowCommon StockSEC:0001437749-22-008454:0
5,000 shares@ US$3.305.7% of flowCommon StockSEC:0001437749-22-002467:0
5,000 shares@ US$3.3012.1% of flowCommon StockSEC:0001437749-22-002467
5,065 shares0Common StockSEC:0001437749-22-002055:0
5,065 shares0Common StockSEC:0001437749-22-002055
2,000 shares@ US$3.752.6% of flowCommon StockSEC:0001437749-22-001472:0
Ideal exit: 21 Oct 2022 (T+270)
2,000 shares@ US$3.755.5% of flowCommon StockSEC:0001437749-22-001472
Ideal exit: 21 Oct 2022 (T+270)
1,132 shares@ US$4.003.3% of flowCommon StockSEC:0001437749-22-001184
Ideal exit: 16 Oct 2022 (T+270)
1,132 shares@ US$4.001.6% of flowCommon StockSEC:0001437749-22-001184:0
Ideal exit: 16 Oct 2022 (T+270)
1,731 shares@ US$4.005.1% of flowCommon StockSEC:0001437749-22-001015
Ideal exit: 11 Oct 2022 (T+270)
1,731 shares@ US$4.002.4% of flowCommon StockSEC:0001437749-22-001015:0
Ideal exit: 11 Oct 2022 (T+270)
2,137 shares@ US$4.006.2% of flowCommon StockSEC:0001437749-22-000925
Ideal exit: 11 Oct 2022 (T+270)
2,137 shares@ US$4.003.0% of flowCommon StockSEC:0001437749-22-000925:0
Ideal exit: 11 Oct 2022 (T+270)
3,000 shares@ US$3.908.7% of flowCommon StockSEC:0001437749-21-028623
Ideal exit: 11 Sept 2022 (T+270)
3,000 shares@ US$3.904.1% of flowCommon StockSEC:0001437749-21-028623:0
Ideal exit: 11 Sept 2022 (T+270)
5,000 shares@ US$4.4016.3% of flowCommon StockSEC:0001437749-21-028294
Ideal exit: 6 Sept 2022 (T+270)
5,000 shares@ US$4.407.7% of flowCommon StockSEC:0001437749-21-028294:0
Ideal exit: 6 Sept 2022 (T+270)
864 shares@ US$4.751.4% of flowCommon StockSEC:0001437749-21-027904:0
Ideal exit: 30 Aug 2022 (T+270)
864 shares@ US$4.753.0% of flowCommon StockSEC:0001437749-21-027904
Ideal exit: 30 Aug 2022 (T+270)
4,136 shares@ US$4.7514.5% of flowCommon StockSEC:0001437749-21-027685
Ideal exit: 29 Aug 2022 (T+270)
4,136 shares@ US$4.756.9% of flowCommon StockSEC:0001437749-21-027685:0
Ideal exit: 29 Aug 2022 (T+270)
5,000 shares@ US$5.0018.5% of flowCommon StockSEC:0001437749-21-027642
Ideal exit: 28 Aug 2022 (T+270)
5,000 shares@ US$5.008.7% of flowCommon StockSEC:0001437749-21-027642:0
Ideal exit: 28 Aug 2022 (T+270)
25 of 29 declarations
About Ostronic Francis Patrick
Francis Patrick Ostronic is an executive at Cyclo Therapeutics, Inc.
